Digital Pathology Market Expected to Reach $1791.30 Million by 2030 : AMR

According to the report published by Allied Market Research, the global digital pathology market garnered $3.79 billion in 2017 and would reach $8.66 billion by 2023, registering a CAGR of 14.8% during the study period, 2017-2023. The report provides comprehensive analyses of the top winning strategies, industry dynamics, market size & estimations, key market segments, and competitive landscape.

Increase in prevalence of cancer cases and rise in adoption of new digital pathology systems boost the growth of the market. For instance, in March 2018, F-Hoffmann La-Roche Ltd. announced the launch of VENTANA DP 200 Slide scanner for digital pathology. The scanner is used to produce images with high quality. In addition, in January 2018, Inspirata acquired the company Omnyx from GE healthcare. This acquisition ensured that Inspirata provided one of the most comprehensive digital pathology solutions. Thus, rise in innovations of new digital pathology systems propels the market growth

Request Report Sample: https://www.alliedmarketresearch.com/request-sample/74

Impact of COVID-19 Pandemic on Digital Pathology Market-

The COVID-19 outbreak is anticipated to have a positive impact to fuel the growth of the global digital pathology market. The Center for Devices and Radiological Health of the U.S. FDA released an enforcement policy for remote digital pathology devices, which are intended for pathologists, clinical laboratories, and drug administration staff. Thus, rise in cases of chronic diseases has increased the usage of digital pathology systems for diagnosis, which is anticipated to drive the digital pathology market during the forecast period.

Thus, new innovations by key players and rise in number of product approvals propel the growth of the market. However, high cost associated with digital pathology systems is expected to hinder the market growth during the forecast period.

Segmentation Analysis of the Industry:

The digital IVD segment captured more than 85% of the market share and would maintain its revenue lead throughout the forecast period, 2017 - 2023. This is because of the increase in prevalence of cancer, diabetes, and other infectious diseases. Nonetheless, the image analysis informatics segment would grow at the fastest CAGR of 20.2% from 2017 to 2023.

The digital PCR segment would manifest the fastest CAGR of 23.6% from 2017 to 2023, owing to its ability to directly count the number of target molecules rather than relying on endogenous controls or reference standards. However, the automated hematology analyzers & blood cell counters segment contributed over one-third of the market share in 2017 and is expected to dominate throughout the forecast period.

Pharma & biotech companies segment accounted for over one-third of the total market share in 2017 and would maintain its lead position by 2023. In addition, this segment would register the highest CAGR of 16.6% from 2017 to 2023.

Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/74

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘:

The study provides an in-depth analysis of the digital pathology market, and the current trends & future estimations to elucidate imminent investment pockets.

It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.

Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Medical Tourism Market--
https://www.alliedmarketresearch.com/medical-tourism-market

Diabetes Therapeutics Market --https://www.alliedmarketresearch.com/diabetes-therapeutics-market

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.